Target intelligence / Profile preview

Mycolic acid (MA)

Target
MA
Molecular classification
Lipid, Long-chain fatty acid, Cell wall component
01

Overview

Mycolic acids are high-molecular-weight, alpha-branched, beta-hydroxy fatty acids that constitute a major and essential component of the cell wall of Mycobacterium species, including Mycobacterium tuberculosis (PubChem, 2024). They form a thick, waxy lipid layer known as the mycomembrane, which provides a formidable permeability barrier against many common antibiotics and host immune effector molecules (Marrakchi et al., 2014). This unique structure is vital for the survival of the bacteria within the harsh environment of the host macrophage and contributes significantly to the pathogen's virulence. Because mycolic acids are unique to the Mycolata taxon and indispensable for bacterial viability, their biosynthetic pathway is the focus of several key anti-tuberculosis therapies (Takayama et al., 2005). Drugs like isoniazid and ethionamide specifically target enzymes involved in the synthesis of these lipids, leading to the disruption of the cell wall and subsequent bacterial lysis (StatPearls, 2023).

Other names
Alpha-mycolic acidMethoxymycolic acidKetomycolic acidMycobacterial fatty acid
02

Mechanism of action

Inhibition of mycolic acid biosynthesis, primarily through the inhibition of the enoyl-ACP reductase (InhA) or other enzymes in the Fatty Acid Synthase II (FAS-II) system (StatPearls, 2023; Takayama et al., 2005).

03

Biological functions

Cell wall structural integrityPermeability barrierVirulence factorImmune evasionProtection against oxidative stress
04

Disease associations

TuberculosisLeprosyNontuberculous mycobacterial infectionInfection
05

Safety considerations

Development of multi-drug resistance (MDR)Hepatotoxicity of associated inhibitorsPoor drug penetration into granulomas
06

Interacting drugs

Isoniazid

5 more in the full profile.

07

Biomarkers

Mycolic acid methyl esters (MAMEs)Tuberculostearic acid

Beyond the preview

Go deeper on Mycolic acid (MA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mycolic acid (MA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call